Topic

drug development

A collection of 2 issues

Biotech Sector Faces Partnership and Development Risks

Explore the biotech sector's challenges with partnerships and drug development risks. Discover the industry's latest trends and potential solutions.

Novo Nordisk's CagriSema Achieves 22.7% Weight Loss

Novo Nordisk's experimental drug CagriSema shows promise with 22.7% weight loss in patients, approaching the anticipated 25%. Discover the latest in weight-loss research.